Kern Ralph Dr. 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Mar 13, 2020
Insider Transaction Report
Form 4
Kern Ralph Dr.
COO and Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-03-09+80,000→ 80,000 totalExercise: $7.33From: 2020-03-09Exp: 2030-03-09→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]Option becomes vested and exercisable as to 25% of the number of shares on each of the first four anniversaries of the grant date until fully vested and exercisable on the fourth anniversary of the grant date.